Status: Recruiting
A Phase II Study Evaluating the Efficacy and Safety of XH-S003 Capsules in Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH)
This is a multicenter, randomized, single-blind Phase II trial to evaluate the efficacy and safety of XH-S003 capsules in PNH patients. About 24 PNH patients will be enrolled and randomized to three dose levels and take XH-S003 capsules orally
Participants needed: 24
Trial details
Phase: Phase 2Age: 18+Biological sex: AllType: InterventionalSponsor: S-INFINITY Pharmaceuticals Co., LtdUpdated: May 18, 2025Locations: 1
Eligibility criteria
Male or female with aged ≥18 years old; [+6]
Subjects with laboratory evidence of bone marrow failure during the screening pe... [+6]